Toxicological Sciences 55, 352-360 (2000)
Copyright © 2000 by the Society of Toxicology
Fingerprinting of Cytochrome P450 and Microsomal Epoxide Hydrolase Gene Expression in Human Blood Cells
Department of Environmental Health, University of Washington, 4225 Roosevelt Way NE #100, Seattle, Washington 98105–6099
To examine the character and variability of human cytochrome P450 (CYP) and microsomal epoxide hydrolase (mEH) gene expression in human blood cells, we used a highly sensitive, quantitative, competitive reverse transcriptase-coupled polymerase chain reaction (QC RT-PCR) assay to assess mRNA profiles for a battery of 8 genes, in peripheral lymphocytes isolated from 10 healthy donors. Of the genes profiled, in lymphocytes CYP2D6 was typically expressed at the highest levels (3.8 x 105 molecules/µg total RNA), with CYP2E1 and mEH also maintained at relatively high abundance (1.2 x 105 and 1.8 x 105 molecules/µg total RNA, respectively). CYP1A1 levels were approximately an order of magnitude lower (3.9 x 104 molecules/µg total RNA), followed by CYP2F1 and CYP3A levels that were near the detection limit of the assay. CYP1A2 and CYP2A6/7 mRNAs were not detected in any of the lymphocyte samples. Overall, relatively low levels of inter-individual variation (2- to 6-fold) existed among these endpoint parameters in the subjects tested. To test whether established human blood cell lines were suitable models to assess basal expression and chemical induction responsiveness of these genes, we determined that constitutive CYP and mEH mRNA profiles were essentially conserved across 4 established human blood cell lines, and highly analogous to the basal expression patterns identified in freshly isolated peripheral lymphocytes. mEH protein was detected in all of the cell lines using Western immunoblotting and chemiluminescent visualization, whereas CYP1A1, CYP2D6, CYP2E1 or CYP3A proteins were not detected in these analyses. When blood cell-derived cultures were exposed to the prototypical CYP1A and CYP3A inducers, i.e., ß-naphthoflavone (ß-NF), dexamethasone (DEX) or phenobarbital, generally little or no inductive response was manifested. Thus, the data obtained from this investigation indicate that, although human blood cell lines in general exhibit poor responsiveness to prototypical inducer exposures, the constitutive patterns of CYP and mEH expression in peripheral lymphocytes appear to exhibit relatively low levels of variation among individuals. In addition, these in vivo patterns of expression are well maintained in established cultured blood-cell lines.
Key Words: biomarkers; blood cells; cytochrome P450 (CYP); human quantitative competitive reverse transcriptase coupled polymerase chain reaction (QC RT-PCR) assay.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Nakayama, I. Riesen, B. Kollner, E. Eppler, and H. Segner Surface Marker-Defined Head Kidney Granulocytes and B Lymphocytes of Rainbow Trout Express Benzo[a]pyrene-Inducible Cytochrome P4501A Protein Toxicol. Sci., May 1, 2008; 103(1): 86 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Siest, E. Jeannesson, J.-B. Marteau, A. Samara, B. Marie, M. Pfister, and S. Visvikis-Siest Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects Drug Metab. Dispos., January 1, 2008; 36(1): 182 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Guo, L. L. Breeden, H. Zarbl, B. D. Preston, and D. L. Eaton Expression of a Human Cytochrome P450 in Yeast Permits Analysis of Pathways for Response to and Repair of Aflatoxin-Induced DNA Damage Mol. Cell. Biol., July 15, 2005; 25(14): 5823 - 5833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Fannin, J. T. Auman, M. E. Bruno, S. O. Sieber, S. M. Ward, C. J. Tucker, B. A. Merrick, and R. S. Paules Differential gene expression profiling in whole blood during acute systemic inflammation in lipopolysaccharide-treated rats Physiol Genomics, March 21, 2005; 21(1): 92 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. McConnachie, B. Phillips, M. Bajpai, D. D. Shen, and R. J. Y. Ho ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES Drug Metab. Dispos., September 1, 2003; 31(9): 1103 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Koch, R. Weil, R. Wolbold, J. Brockmoller, E. Hustert, O. Burk, A. Nuessler, P. Neuhaus, M. Eichelbaum, U. Zanger, et al. Interindividual Variability and Tissue-Specificity in the Expression of Cytochrome P450 3A mRNA Drug Metab. Dispos., October 1, 2002; 30(10): 1108 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Nowakowski-Gashaw, P. M. Mrozikiewicz, I. Roots, and J. Brockmoller Rapid Quantification of CYP3A4 Expression in Human Leukocytes by Real-Time Reverse Transcription-PCR Clin. Chem., February 1, 2002; 48(2): 366 - 370. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schilter, M. R. Andersen, C. Acharya, and C. J. Omiecinski Activation of Cytochrome P450 Gene Expression in the Rat Brain by Phenobarbital-Like Inducers J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 916 - 922. [Abstract] [Full Text]
|
|